Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 54 results for "novartis india"

Novartis India slips 4%
India Infoline

Opportunity in the Indian Cardiovascular Pharmaceuticals Marke...

FEATURED COMPANIES Aventis Pharma Limited Cipla Limited Lupin Limited Merck Limited Novartis India Limited Pfizer Limited MORE This report provides an insight into the ... Research and Markets, 3 weeks ago
Novartis drops after reporting loss in Q3 Business Standard India, 1 month ago
[x]  

28 images for novartis india

Chicago Daily Herald, 1 month ago
BDlive, 4 weeks ago
FDA News, 1 month ago
India Infoline, 1 month ago
India TV, 3 months ago
NDTV Profit, 3 months ago
Pharmaceutical Technology, 2 months ago
First Post.com, 2 months ago
Business Standard, 2 months ago
Yahoo! News, 2 months ago
NDTV Profit

GSK PHARMA TO TRANSFER CANCER PORTFOLIO TO NOVARTIS ARM

GlaxoSmithKline Pharmaceuticals (GSK) will transfer its cancer drugs portfolio to an arm of Novartis India as part of a global deal between the two companies. In turn, GSK will acquire the vaccines division of Novartis .
 4 Traders1 month ago GSK Pharma to transfer cancer drug portfolio to Novartis arm  Business Standard1 month ago GlaxoSmithKline Pharma Q3 Net Declines 61% to Rs 45 Crore  NDTV Profit1 month ago
[x]  

Novartis India to hold board meeting

On 4 February 2015
 Business Standard2 months ago Outcome of board meeting of Novartis India  Business Standard2 months ago
Business Standard

Novartis India : OKAYS OTC UNIT SALE

Novartis India Ltd has secured the approval of its board for the slump sale of its over-the-counter (OTC) division to GlaxoSmithKline Consumer Pvt Ltd (GSK). The slump sale would take place on or before 22 Oct 2015 for a consideration of ...
 4 Traders1 month ago NOVARTIS OKAYS OTC UNIT FOR SALE TO GSK FOR Rs109.7 CRORE  4 Traders2 months ago Novartis India to sell OTC business to GSK Consumer for Rs 109 cr  Business Standard2 months ago Novartis okays OTC unit sale to GSK Consumer for Rs 109.7-cr  Business Standard2 months ago

NOVARTIS BOARD OKAYS TRANSFER OF OTC BUSINESS TO GSK FOR Rs109 CRORE

The board of Novartis India has approved the transfer of its over-the- counter (OTC) business to GlaxoSmithKline Consumer Pvt Ltd (GSK) for Rs109 crore . The company is waiting for the regulatory approvals to complete the deal. Novartis , GSK ...
 4 Traders2 months ago Novartis India slips as board approves transfer of OTC business  Business Standard2 months ago
IFSEC Global

Gunnebo India announces Sabyasachi Sengupta as New Country Manager and MD

Gunnebo India has appointed Sabyasachi Sengupta, formerly itsexecutive director of finance, as its new country manager and managing director. The newly promoted Sengupta has been associated with Gunnebo since 2008 and has been in the industry for ...
 IFSEC Global3 weeks ago Gunnebo India elevates senior executives  Security Today1 month ago Sabyasachi Sengupta is Country Manager for Gunnebo India  ChannelWorld India1 month ago
Pharmaceutical Technology

GSK completes $20bn three-part deal with Swiss Novartis

GlaxoSmithKline (GSK) has completed a three-part transaction worth more than $20bn with Switzerland-based Novartis. As part of the deal, GSK has acquired Novartis's global Vaccines business, excluding influenza vaccines, for an initial cash ...
 Pharmaceutical Technology4 weeks ago GSK and Novartis three-part transaction receives European approval  Pharmaceutical Technology2 months ago

Growth agenda on track, says India Inc

MUMBAI: BJP's massive defeat in Delhi, just two weeks before the Union Budget, is unlikely to impact the government's plans of charting out a plan to boost economic growth. Although stunned by the extent of AAP's victory in the capital, which ...
 Times of India1 month ago Budget 2015: Growth agenda on track, says India Inc  Economic Times1 month ago
Business Today India

Obama visit may pressurise govt to dilute patent laws: MSF

US President Barack Obama's visit to India is likely to accelerate ongoing pressure from the US on the Indian government to dilute its patent laws to help multinational drug makers, fears international medical humanitarian organisation Medecins Sans ...
 Business Today India2 months ago
Rediff.com

Cipla moves HC against bar on sale of generic drug [India Business] [Times of India]

MUMBAI: Cipla has filed an appeal in the Delhi high court against a recent order which restrained it from selling its generic version of Novartis drug Onbrez in the domestic market. The matter is expected to come up for a hearing on Wednesday. ...
 Pharmacy Choice2 months ago Court bars Cipla from selling copy of Novartis respiratory drug  Rediff.com2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less